GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai OPM Biosciences Co Ltd (SHSE:688293) » Definitions » Debt-to-Equity

Shanghai OPM Biosciences Co (SHSE:688293) Debt-to-Equity : 0.03 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai OPM Biosciences Co Debt-to-Equity?

Shanghai OPM Biosciences Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥11.6 Mil. Shanghai OPM Biosciences Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥58.5 Mil. Shanghai OPM Biosciences Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,153.4 Mil. Shanghai OPM Biosciences Co's debt to equity for the quarter that ended in Mar. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai OPM Biosciences Co's Debt-to-Equity or its related term are showing as below:

SHSE:688293' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03   Med: 0.05   Max: 0.62
Current: 0.03

During the past 6 years, the highest Debt-to-Equity Ratio of Shanghai OPM Biosciences Co was 0.62. The lowest was 0.03. And the median was 0.05.

SHSE:688293's Debt-to-Equity is ranked better than
82.26% of 1060 companies
in the Biotechnology industry
Industry Median: 0.14 vs SHSE:688293: 0.03

Shanghai OPM Biosciences Co Debt-to-Equity Historical Data

The historical data trend for Shanghai OPM Biosciences Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai OPM Biosciences Co Debt-to-Equity Chart

Shanghai OPM Biosciences Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial 0.62 0.20 0.22 0.04 0.03

Shanghai OPM Biosciences Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.03 0.03 0.03

Competitive Comparison of Shanghai OPM Biosciences Co's Debt-to-Equity

For the Biotechnology subindustry, Shanghai OPM Biosciences Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai OPM Biosciences Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai OPM Biosciences Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai OPM Biosciences Co's Debt-to-Equity falls into.



Shanghai OPM Biosciences Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai OPM Biosciences Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shanghai OPM Biosciences Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai OPM Biosciences Co  (SHSE:688293) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Shanghai OPM Biosciences Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai OPM Biosciences Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai OPM Biosciences Co (SHSE:688293) Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Lane 908, Ziping Road, Pudong New Area, Shanghai, CHN, 201321
Shanghai OPM Biosciences Co Ltd is a biotechnology company focusing on providing cell culture solutions and end-to-end CDMO services.
Executives
Xiao Zhi Hua Director
Ni Liang Ping Director

Shanghai OPM Biosciences Co (SHSE:688293) Headlines

No Headlines